Velosity Lab accelerates medtech launches with advanced tools, cutting lead times and driving innovation in medical device ...

Rolling submission of Biologics License Agreement (BLA) to U.S. Food and Drug Administration (FDA) seeking ST-920 approval is in progress.Six ...

Polyendocrine metabolic ovarian syndrome, or PMOS, will now be used to describe the condition that affects around one in ...

As pet owners treat animals like children, the demand for longevity medicine is skyrocketing, creating a bridge for ...

Even as tech surges, many other sectors in the market are trading at surprisingly attractive prices.

CMS launches its Medicare GLP-1 Bridge July 1, giving eligible Medicare Part D beneficiaries access to weight-loss GLP-1s at a $50 monthly copay through December 2027. For health systems and pharmacy ...

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

Viral load. As health officials continue to monitor the rare and deadly Andes strain of hantavirus that spread across the MV ...

Gourd news for parents trying to raise healthy eaters! It turns out that the battle to get kids to eat their veggies starts much earlier than you might think — like in the womb — so mothers have a ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

Market opportunities include comprehensive training on ISO 10993 standards compliance, essential for meeting EU Medical Device Regulation safety requirements. This course equips participants with risk ...